← All companies

TNDM

Tandem Diabetes Care, Inc.

TNDM Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗

$20.11

+1.10 +5.79%

Key statistics

from XBRL data in SEC filings

Market cap

$1.38B

Revenue (TTM)

$1.03B

Net income (TTM)

-$94.5M

EPS (TTM)

$-1.40

P/E ratio

—

Dividend yield

—

Free cash flow

-$29.7M

Cash

$179M

Total assets

$1.15B

Gross margin

54.9%

52-week range

$9.98 – $29.65

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Modified rights of security holders; Director or officer change; Shareholder vote results May 21, 2026 8-K Director or officer change May 15, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Feb 27, 2026 10-K Fiscal year ended 2025-12-31 Feb 19, 2026 8-K Results of operations (earnings release) Feb 19, 2026 8-K Amended charter or bylaws Dec 30, 2025 8-K Director or officer change Nov 12, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Other events Aug 7, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Entered a material agreement; Shareholder vote results May 23, 2025 8-K Other events May 20, 2025 8-K Other events May 12, 2025 10-Q Quarter ended 2025-03-31 Apr 30, 2025 8-K Results of operations (earnings release) Apr 30, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Results of operations (earnings release) Feb 26, 2025 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Aug 1, 2024 8-K Director or officer change Jun 21, 2024 8-K Entered a material agreement Jun 18, 2024 8-K Director or officer change; Shareholder vote results May 23, 2024 8-K Entered a material agreement; Other events May 16, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release) May 2, 2024 8-K Other events Apr 1, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Mar 11, 2024 10-K Fiscal year ended 2023-12-31 Feb 21, 2024 8-K Results of operations (earnings release) Feb 21, 2024 8-K Director or officer change Dec 11, 2023 8-K Director or officer change Nov 13, 2023 8-K Other events Nov 6, 2023 10-Q Quarter ended 2023-09-30 Nov 1, 2023 8-K Results of operations (earnings release) Nov 1, 2023